Skip to content

Effects of Continuous Moderate-Intensity Training Combined with Whole-Body Vibration Training on Blood Lipids, Glucose Metabolism, and Cardiopulmonary Function in Patients with Chronic Coronary Syndrome: A Randomized, Single-Center, Interventional Clinical Study

Effects of Continuous Moderate-Intensity Training Combined with Whole-Body Vibration Training on Blood Lipids, Glucose Metabolism, and Cardiopulmonary Function in Patients with Chronic Coronary Syndrome: A Randomized, Single-Center, Interventional Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115191
Enrollment
Unknown
Registered
2025-12-23
Start date
2025-12-30
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic coronary syndrome

Interventions

Continuous moderate-intensity combined whole-body vibration training Group:Continuous moderate-intensity combined whole-body vibration training
Continuous Moderate-Intensity Training Group:Continuous Moderate-Intensity Aerobic Training

Sponsors

The First People's Hostipal of Zhaoqing
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Voluntarily participate in the trial and sign the informed consent form; 2.Aged between 18 and 75 years, no gender restriction; 3.Able to cooperate with examination and treatment; 4.Belongs to any of the following types of chronic coronary syndromes: Stable angina: persistent chest pain symptoms, but the condition is relatively stable; Ischemic cardiomyopathy: long-term ischemia of the myocardium leading to impaired heart function; Hospitalized for acute coronary syndrome or coronary revascularization, discharged after the condition stabilizes; Vasospastic or microvascular angina: ischemic chest pain caused by vascular spasm or microcirculatory disorders; Asymptomatic coronary artery disease: severe coronary artery stenosis is present, but no obvious symptoms have appeared yet.

Exclusion criteria

Exclusion criteria: 1.Those who have had a myocardial infarction or undergone coronary revascularization within 1 month; 2.Patients with other heart diseases, neurasthenia, menopausal syndrome, hyperthyroidism, and other conditions that may cause chest pain. 3.Individuals with severe liver and kidney dysfunction; 4.Those with severe primary diseases such as combined respiratory or blood system disorders or malignant tumors; 5.Pregnant women, breastfeeding women, or women of childbearing age with fertility requirements; 6.There is a mental illness; 7.Expected poor compliance, unable to follow up regularly; 8.Excluding diseases that affect limb movement, such as knee joint movement disorders, muscle lesions, and mental disorders. 9.Researchers believe there are other circumstances in which participation in the study is not appropriate.

Design outcomes

Primary

MeasureTime frame
Biochemical markers (blood glucose, blood lipids, triglyceride-glucose index);Exercise tolerance(VO2 peak and anaerobic threshold);

Secondary

MeasureTime frame
major adverse cardiovascular events;Quality of life indicators (SF-12 Quality of Life Scale);

Countries

China

Contacts

Public ContactXiu Jian

The First People's Hostipal of Zhaoqing

woxinzizai123@163.com+86 758 2102826

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026